Literature DB >> 7722459

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.

J Hammer1, F Gallazzi, E Bono, R W Karr, J Guenot, P Valsasnini, Z A Nagy, F Sinigaglia.   

Abstract

We have investigated whether sequence 67 to 74 shared by beta chains of rheumatoid arthritis (RA)-associated HLA-DR molecules imparts a specific pattern of peptide binding. The peptide binding specificity of the RA-associated molecules, DRB1*0401, DRB1*0404, and the closely related, RA nonassociated DRB1*0402 was, therefore, determined using designer peptide libraries. The effect of single key residues was tested with site-directed mutants of DRB1*0401. The results have demonstrated striking differences between RA-linked and unlinked DR allotypes in selecting the portion of peptides that interacts with the 67-74 area. Most differences were associated with a single amino acid exchange at position 71 of the DR beta chain, and affected the charge of residues potentially contacting position 71. The observed binding patterns permitted an accurate prediction of natural protein derived peptide sequences that bind selectively to RA-associated DR molecules. Thus, the 67-74 region, in particular position 71, induces changes of binding specificity that correlate with the genetic linkage of RA susceptibility. These findings should facilitate the identification of autoantigenic peptides involved in the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722459      PMCID: PMC2191993          DOI: 10.1084/jem.181.5.1847

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

Authors:  M Simon; E Girbal; M Sebbag; V Gomès-Daudrix; C Vincent; G Salama; G Serre
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 2.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

Authors:  P K Gregersen; J Silver; R J Winchester
Journal:  Arthritis Rheum       Date:  1987-11

3.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

4.  Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells.

Authors:  H S Teh; P Kisielow; B Scott; H Kishi; Y Uematsu; H Blüthmann; H von Boehmer
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

5.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

6.  High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

Authors:  J Hammer; C Belunis; D Bolin; J Papadopoulos; R Walsky; J Higelin; W Danho; F Sinigaglia; Z A Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan.

Authors:  K Mikecz; T T Glant; A R Poole
Journal:  Arthritis Rheum       Date:  1987-03

8.  Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.

Authors:  J Hammer; E Bono; F Gallazzi; C Belunis; Z Nagy; F Sinigaglia
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

9.  Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.

Authors:  X T Fu; C P Bono; S L Woulfe; C Swearingen; N L Summers; F Sinigaglia; A Sette; B D Schwartz; R W Karr
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  73 in total

1.  Uncovering a Shared Epitope-Activated Protein Citrullination Pathway.

Authors:  Vincent van Drongelen; Wahida H Ali; Joseph Holoshitz
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

Review 2.  Association of MHC and rheumatoid arthritis. Regulatory role of HLA class II molecules in animal models of RA: studies on transgenic/knockout mice.

Authors:  V Taneja; C S David
Journal:  Arthritis Res       Date:  2000-04-12

Review 3.  A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules.

Authors:  Zoltan A Nagy; Nuala A Mooney
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

4.  Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.

Authors:  Chu-Young Kim; Hanne Quarsten; Elin Bergseng; Chaitan Khosla; Ludvig M Sollid
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-12       Impact factor: 11.205

5.  The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis.

Authors:  J M Greer; M P Pender
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

6.  Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4.

Authors:  Erik Evensen; Diane Joseph-McCarthy; Gregory A Weiss; Stuart L Schreiber; Martin Karplus
Journal:  J Comput Aided Mol Des       Date:  2007-07-27       Impact factor: 3.686

7.  Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.

Authors:  Hüseyin Duyar; Jörn Dengjel; Katrien L de Graaf; Karl-Heinz Wiesmüller; Stefan Stevanović; Robert Weissert
Journal:  Immunogenetics       Date:  2005-02-12       Impact factor: 2.846

Review 8.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

9.  HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method.

Authors:  A M Valdes; S McWeeney; G Thomson
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

10.  HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.

Authors:  Bettina Panagiota Iliopoulou; Mireia Guerau-de-Arellano; Brigitte T Huber
Journal:  Arthritis Rheum       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.